News | Digital Pathology | May 28, 2019

Alverno Laboratories Implementing Philips IntelliSite Pathology Solution

Large Midwest laboratory goes digital to further enhance efficiencies and quality of diagnostics for histology cases

Alverno Laboratories Implementing Philips IntelliSite Pathology Solution

May 28, 2019 — Philips and Alverno Laboratories, a provider of high-quality diagnostic testing services, announced that Alverno will fully implement digital pathology in its clinical laboratories. The laboratory network will use Philips IntelliSite Pathology Solution to assess and diagnose all clinical histology cases digitally, instead of using a microscope, with the aim of improving laboratory efficiency, quality and patient safety.

Pathology plays a critical role in disease detection, particularly with cancer diagnosis. Suspicious tissue samples are investigated to determine if the tissue is malignant and consequently guides treatment decisions. As one of the largest pathology laboratories in the Midwest, Alverno manages 33 hospital laboratories, and provides laboratory services to two freestanding emergency departments and thousands of physician offices and other clients. Alverno consults on more than 142,000 histological cases each year, which translates to more than 1,100,000 slides of human tissue. Currently, each of these slides needs to be prepared, analyzed through a microscope, diagnosed, reported and archived. Digitizing these images will ease collaboration across sites and help reduce costs.

“Alverno is committed to ensuring our patients and clinical colleagues receive the fastest, most effective and best-informed diagnoses possible by employing the latest technology innovations,” said Sam Terese, CEO of Alverno Laboratories. “Digital pathology enables enhanced cooperation and access to sub-specialists, helping us improve turnaround times and ultimately advancing our goal of saving lives.”

Philips IntelliSite Pathology Solution is an automated digital pathology image creation, viewing and management system comprising the Ultra Fast Scanner, the Image Management System and Display for clinical IVD use. This solution contains advanced software tools to manage the scanning, storage, presentation, reviewing and sharing of images. By supporting the transition to digital workflows, Philips seeks to help pathology laboratories simplify access to histopathology information and implement more efficient workflows.

The Philips IntelliSite Pathology Solution is the first digital pathology solution marketed for primary diagnostic use in the U.S, for all formalin-fixed paraffin-embedded (FFPE) surgical pathology slides, including hematoxylin and eosin (H&E), special stains and immunohistochemistry.

For more information: www.usa.philips.com/healthcare

Related Content

Volpara Health announced two new research studies using AI-powered software to score breast density objectively and consistently to evaluate its impact in mammography and breast cancer risk assessment.
News | Breast Density | December 30, 2020
December 30, 2020 — Volpara Health announced two new research studies using...
Company delivers on last year’s roadmap milestones and continues to advance cloud-native suite of tools to lead industry to the future of enterprise imaging
News | Enterprise Imaging | December 23, 2020
December 23, 2020 — ...
 EvoHealth, a trailblazer in incorporating new technology in healthcare IT software, announced it has exceeded its first milestone of more than 100 customers with over 200 locations.
News | Information Technology | December 22, 2020
December 22, 2020 — EvoHealth, a trailblazer in incorporating n
The Radiological Society of North America (RSNA) and the RSNA COVID-19 AI Task Force announced that the first annotated data set from the RSNA International COVID-19 Open Radiology Database (RICORD) has been published by The Cancer Imaging Archive (TCIA).

Getty Images

News | Coronavirus (COVID-19) | December 21, 2020
December 21, 2020 — The Radiological Society of North America (RSNA
The key trends oClinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | December 17, 2020 | By Melinda Taschetta-Millane and Dave Fornell
The Radiological Society of North America’s 106th Scientific Assembly and Annual Meeting (RSNA 2020) held November 30 to December 5 as an entirely virtual event, attracted a virtual audience of 29,339 people from 134 countries worldwide.

Getty Images

News | RSNA | December 15, 2020
December 15, 2020 — The Radiological Society of North America’s
Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose management application.
News | Radiation Dose Management | December 11, 2020
December 11, 2020 — Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose manag
An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

News | Coronavirus (COVID-19) | December 08, 2020
December 8, 2020 — After recovering from COVID-19